chr6-160130197-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003057.3(SLC22A1):āc.505T>Cā(p.Phe169Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003057.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A1 | NM_003057.3 | c.505T>C | p.Phe169Leu | missense_variant | 2/11 | ENST00000366963.9 | NP_003048.1 | |
SLC22A1 | NM_153187.2 | c.505T>C | p.Phe169Leu | missense_variant | 2/10 | NP_694857.1 | ||
SLC22A1 | XM_005267103.3 | c.505T>C | p.Phe169Leu | missense_variant | 2/12 | XP_005267160.1 | ||
SLC22A1 | XM_006715552.3 | c.505T>C | p.Phe169Leu | missense_variant | 2/9 | XP_006715615.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A1 | ENST00000366963.9 | c.505T>C | p.Phe169Leu | missense_variant | 2/11 | 1 | NM_003057.3 | ENSP00000355930 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151978Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251338Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135824
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461524Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727086
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151978Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74234
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.505T>C (p.F169L) alteration is located in exon 2 (coding exon 2) of the SLC22A1 gene. This alteration results from a T to C substitution at nucleotide position 505, causing the phenylalanine (F) at amino acid position 169 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at